Background to the report

The failure of Greensill Capital in March 2021 has triggered several reviews and investigations. On 16 April 2021 the Prime Minister commissioned Nigel Boardman to examine the development and use of supply chain finance by Greensill Capital in government. This report was published on 22 July 2021 and recommendations were issued shortly afterwards. The Treasury Select Committee held oral evidence sessions on 13 and 27 May 2021 and published a report on the lessons from Greensill Capital on 20 July 2021. The Committee of Public Accounts held its own sessions on lessons from Greensill Capital on 22 April, 13 May and 22 July 2021. Witnesses at the evidence sessions included former Prime Minister, David Cameron and Lex Greensill, founder of Greensill Capital.

Jump to downloads

Following the hearings by the select committees, the Comptroller and Auditor General decided to examine Greensill Capital’s involvement in supply chain finance for community pharmacies and NHS employees – given recent events and the Committee of Public Accounts’ interest in this area.

Scope of the report

This investigation examines Greensill Capital’s involvement in the provision of two schemes to the NHS – firstly, supply chain finance – with particular focus on the Pharmacy Earlier Payment Scheme to pharmacy contractors; and secondly, the Employer Salary Advance Scheme which allowed NHS employees to access their earned salaries in advance of payday. Supply chain finance is a financial transaction whereby a lender finances a supplier on behalf of the customer. The investigation also considers the impact of the failure of Greensill Capital in March 2021 on the government, taxpayers, and NHS organisations to which it provided its services.

The first scheme, known as the Pharmacy Earlier Payment Scheme (PEPS) was an arrangement administered by NHS Business Services Authority (NHSBSA) and contracted to Taulia Inc and its subcontractor Greensill Capital. PEPS enabled pharmacy contractors in England to be reimbursed for dispensing prescriptions earlier than the normal payment timetable by accessing private capital advanced by Greensill Capital, which Greensill Capital later collected from NHSBSA. The second scheme, known as Earnd and provided through Earnd UK (a company owned by Greensill Capital), was a salary advance scheme used by some NHS trusts in England. It allowed employees to receive a proportion of their earnings before payday without paying fees.


Publication details

Press release

View press release (29 Oct 2021)

Latest reports